Awareness, treatment and control of cardiometabolic disorders in Chinese adults with diabetes

A national representative population study

Tiange Wang, Yu Xu, Min Xu, Weiqing Wang, Yufang Bi, Jieli Lu, Meng Dai, Di Zhang, Lin Ding, Baihui Xu, Jichao Sun, Wenhua Zhao, Yong Jiang, Limin Wang, Yichong Li, Mei Zhang, Shenghan Lai, Linhong Wang, Guang Ning

Research output: Contribution to journalArticle

Abstract

Background: The diagnosis of diabetes has important clinic implications for the prevention and management of cardiometabolic disorders. We aimed to investigate the awareness, treatment and control of hypertension and dyslipidemia in previously-diagnosed and newly-diagnosed diabetes in Chinese adult population. Methods: We conducted a cross-sectional survey in a nationally representative sample of 98658 Chinese adults aged 18years or older in 2010, using a complex, multistage, probability sampling design. Glycemic status were defined according to the 2010 American Diabetes Association criteria. Hypertension was diagnosed by the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Dyslipidemia was diagnosed by the 2004 National Cholesterol Education Program Adult Treatment Panel III. Results: The weighted prevalence of hypertension and dyslipidemia gradually increased in adults with normal glucose regulation, prediabetes, newly-diagnosed diabetes and previously-diagnosed diabetes. Compared to newly-diagnosed diabetes patients, previously-diagnosed diabetes patients were more likely to be aware of hypertension (weighted percentage [95% confidence interval]: 55.2% [52.9%-57.5%] vs 37.6% [35.9%-39.3%]) and dyslipidemia (33.9% [31.8%-36.1%] vs 12.8% [11.7%-13.9%]), to receive blood pressure-lowing (43.7% [41.5%-46.0%] vs 27.5% [26.0%-29.0%]) and lipid-lowering (18.9% [17.2%-20.7%] vs 5.4% [4.6%-6.2%]) therapies, and to have controlled blood pressure (4.7% [3.5%-6.2%] vs 3.5% [2.6%-4.8%]) and lipid (15.9% [12.3%-20.3%] vs 9.5% [6.4%-13.8%]) levels. Conclusions: Detection and control of hypertension and dyslipidemia is far from optimal in Chinese adults, especially in newly-diagnosed diabetes. Improved screening for diabetes is required to promote a better prevention, treatment and control of hypertension and dyslipidemia in China.

Original languageEnglish (US)
Article number28
JournalCardiovascular Diabetology
Volume14
Issue number1
DOIs
StatePublished - Feb 26 2015

Fingerprint

Dyslipidemias
Hypertension
Population
Therapeutics
Blood Pressure
Lipids
Prediabetic State
China
Cross-Sectional Studies
Cholesterol
Confidence Intervals
Education
Glucose

Keywords

  • China
  • Control
  • Diabetes
  • Dyslipidemia
  • Hypertension

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Awareness, treatment and control of cardiometabolic disorders in Chinese adults with diabetes : A national representative population study. / Wang, Tiange; Xu, Yu; Xu, Min; Wang, Weiqing; Bi, Yufang; Lu, Jieli; Dai, Meng; Zhang, Di; Ding, Lin; Xu, Baihui; Sun, Jichao; Zhao, Wenhua; Jiang, Yong; Wang, Limin; Li, Yichong; Zhang, Mei; Lai, Shenghan; Wang, Linhong; Ning, Guang.

In: Cardiovascular Diabetology, Vol. 14, No. 1, 28, 26.02.2015.

Research output: Contribution to journalArticle

Wang, T, Xu, Y, Xu, M, Wang, W, Bi, Y, Lu, J, Dai, M, Zhang, D, Ding, L, Xu, B, Sun, J, Zhao, W, Jiang, Y, Wang, L, Li, Y, Zhang, M, Lai, S, Wang, L & Ning, G 2015, 'Awareness, treatment and control of cardiometabolic disorders in Chinese adults with diabetes: A national representative population study', Cardiovascular Diabetology, vol. 14, no. 1, 28. https://doi.org/10.1186/s12933-015-0191-6
Wang, Tiange ; Xu, Yu ; Xu, Min ; Wang, Weiqing ; Bi, Yufang ; Lu, Jieli ; Dai, Meng ; Zhang, Di ; Ding, Lin ; Xu, Baihui ; Sun, Jichao ; Zhao, Wenhua ; Jiang, Yong ; Wang, Limin ; Li, Yichong ; Zhang, Mei ; Lai, Shenghan ; Wang, Linhong ; Ning, Guang. / Awareness, treatment and control of cardiometabolic disorders in Chinese adults with diabetes : A national representative population study. In: Cardiovascular Diabetology. 2015 ; Vol. 14, No. 1.
@article{18058225666f415cbfefdd18dbf5d107,
title = "Awareness, treatment and control of cardiometabolic disorders in Chinese adults with diabetes: A national representative population study",
abstract = "Background: The diagnosis of diabetes has important clinic implications for the prevention and management of cardiometabolic disorders. We aimed to investigate the awareness, treatment and control of hypertension and dyslipidemia in previously-diagnosed and newly-diagnosed diabetes in Chinese adult population. Methods: We conducted a cross-sectional survey in a nationally representative sample of 98658 Chinese adults aged 18years or older in 2010, using a complex, multistage, probability sampling design. Glycemic status were defined according to the 2010 American Diabetes Association criteria. Hypertension was diagnosed by the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Dyslipidemia was diagnosed by the 2004 National Cholesterol Education Program Adult Treatment Panel III. Results: The weighted prevalence of hypertension and dyslipidemia gradually increased in adults with normal glucose regulation, prediabetes, newly-diagnosed diabetes and previously-diagnosed diabetes. Compared to newly-diagnosed diabetes patients, previously-diagnosed diabetes patients were more likely to be aware of hypertension (weighted percentage [95{\%} confidence interval]: 55.2{\%} [52.9{\%}-57.5{\%}] vs 37.6{\%} [35.9{\%}-39.3{\%}]) and dyslipidemia (33.9{\%} [31.8{\%}-36.1{\%}] vs 12.8{\%} [11.7{\%}-13.9{\%}]), to receive blood pressure-lowing (43.7{\%} [41.5{\%}-46.0{\%}] vs 27.5{\%} [26.0{\%}-29.0{\%}]) and lipid-lowering (18.9{\%} [17.2{\%}-20.7{\%}] vs 5.4{\%} [4.6{\%}-6.2{\%}]) therapies, and to have controlled blood pressure (4.7{\%} [3.5{\%}-6.2{\%}] vs 3.5{\%} [2.6{\%}-4.8{\%}]) and lipid (15.9{\%} [12.3{\%}-20.3{\%}] vs 9.5{\%} [6.4{\%}-13.8{\%}]) levels. Conclusions: Detection and control of hypertension and dyslipidemia is far from optimal in Chinese adults, especially in newly-diagnosed diabetes. Improved screening for diabetes is required to promote a better prevention, treatment and control of hypertension and dyslipidemia in China.",
keywords = "China, Control, Diabetes, Dyslipidemia, Hypertension",
author = "Tiange Wang and Yu Xu and Min Xu and Weiqing Wang and Yufang Bi and Jieli Lu and Meng Dai and Di Zhang and Lin Ding and Baihui Xu and Jichao Sun and Wenhua Zhao and Yong Jiang and Limin Wang and Yichong Li and Mei Zhang and Shenghan Lai and Linhong Wang and Guang Ning",
year = "2015",
month = "2",
day = "26",
doi = "10.1186/s12933-015-0191-6",
language = "English (US)",
volume = "14",
journal = "Cardiovascular Diabetology",
issn = "1475-2840",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Awareness, treatment and control of cardiometabolic disorders in Chinese adults with diabetes

T2 - A national representative population study

AU - Wang, Tiange

AU - Xu, Yu

AU - Xu, Min

AU - Wang, Weiqing

AU - Bi, Yufang

AU - Lu, Jieli

AU - Dai, Meng

AU - Zhang, Di

AU - Ding, Lin

AU - Xu, Baihui

AU - Sun, Jichao

AU - Zhao, Wenhua

AU - Jiang, Yong

AU - Wang, Limin

AU - Li, Yichong

AU - Zhang, Mei

AU - Lai, Shenghan

AU - Wang, Linhong

AU - Ning, Guang

PY - 2015/2/26

Y1 - 2015/2/26

N2 - Background: The diagnosis of diabetes has important clinic implications for the prevention and management of cardiometabolic disorders. We aimed to investigate the awareness, treatment and control of hypertension and dyslipidemia in previously-diagnosed and newly-diagnosed diabetes in Chinese adult population. Methods: We conducted a cross-sectional survey in a nationally representative sample of 98658 Chinese adults aged 18years or older in 2010, using a complex, multistage, probability sampling design. Glycemic status were defined according to the 2010 American Diabetes Association criteria. Hypertension was diagnosed by the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Dyslipidemia was diagnosed by the 2004 National Cholesterol Education Program Adult Treatment Panel III. Results: The weighted prevalence of hypertension and dyslipidemia gradually increased in adults with normal glucose regulation, prediabetes, newly-diagnosed diabetes and previously-diagnosed diabetes. Compared to newly-diagnosed diabetes patients, previously-diagnosed diabetes patients were more likely to be aware of hypertension (weighted percentage [95% confidence interval]: 55.2% [52.9%-57.5%] vs 37.6% [35.9%-39.3%]) and dyslipidemia (33.9% [31.8%-36.1%] vs 12.8% [11.7%-13.9%]), to receive blood pressure-lowing (43.7% [41.5%-46.0%] vs 27.5% [26.0%-29.0%]) and lipid-lowering (18.9% [17.2%-20.7%] vs 5.4% [4.6%-6.2%]) therapies, and to have controlled blood pressure (4.7% [3.5%-6.2%] vs 3.5% [2.6%-4.8%]) and lipid (15.9% [12.3%-20.3%] vs 9.5% [6.4%-13.8%]) levels. Conclusions: Detection and control of hypertension and dyslipidemia is far from optimal in Chinese adults, especially in newly-diagnosed diabetes. Improved screening for diabetes is required to promote a better prevention, treatment and control of hypertension and dyslipidemia in China.

AB - Background: The diagnosis of diabetes has important clinic implications for the prevention and management of cardiometabolic disorders. We aimed to investigate the awareness, treatment and control of hypertension and dyslipidemia in previously-diagnosed and newly-diagnosed diabetes in Chinese adult population. Methods: We conducted a cross-sectional survey in a nationally representative sample of 98658 Chinese adults aged 18years or older in 2010, using a complex, multistage, probability sampling design. Glycemic status were defined according to the 2010 American Diabetes Association criteria. Hypertension was diagnosed by the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Dyslipidemia was diagnosed by the 2004 National Cholesterol Education Program Adult Treatment Panel III. Results: The weighted prevalence of hypertension and dyslipidemia gradually increased in adults with normal glucose regulation, prediabetes, newly-diagnosed diabetes and previously-diagnosed diabetes. Compared to newly-diagnosed diabetes patients, previously-diagnosed diabetes patients were more likely to be aware of hypertension (weighted percentage [95% confidence interval]: 55.2% [52.9%-57.5%] vs 37.6% [35.9%-39.3%]) and dyslipidemia (33.9% [31.8%-36.1%] vs 12.8% [11.7%-13.9%]), to receive blood pressure-lowing (43.7% [41.5%-46.0%] vs 27.5% [26.0%-29.0%]) and lipid-lowering (18.9% [17.2%-20.7%] vs 5.4% [4.6%-6.2%]) therapies, and to have controlled blood pressure (4.7% [3.5%-6.2%] vs 3.5% [2.6%-4.8%]) and lipid (15.9% [12.3%-20.3%] vs 9.5% [6.4%-13.8%]) levels. Conclusions: Detection and control of hypertension and dyslipidemia is far from optimal in Chinese adults, especially in newly-diagnosed diabetes. Improved screening for diabetes is required to promote a better prevention, treatment and control of hypertension and dyslipidemia in China.

KW - China

KW - Control

KW - Diabetes

KW - Dyslipidemia

KW - Hypertension

UR - http://www.scopus.com/inward/record.url?scp=84925186140&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925186140&partnerID=8YFLogxK

U2 - 10.1186/s12933-015-0191-6

DO - 10.1186/s12933-015-0191-6

M3 - Article

VL - 14

JO - Cardiovascular Diabetology

JF - Cardiovascular Diabetology

SN - 1475-2840

IS - 1

M1 - 28

ER -